Why the study?
Does a low-dose heparin regimen reduce bleeding and transfusion requirements compared to standard high-dose anticoagulation in patients undergoing CABG with minimal cardiopulmonary bypass?
Does a low-dose heparin regimen reduce bleeding and transfusion requirements compared to standard high-dose anticoagulation in patients undergoing CABG with minimal cardiopulmonary bypass?
An individually tailored low-dose heparin regimen for minimal cardiopulmonary bypass is safe and significantly reduces postoperative bleeding and transfusion requirements compared to standard high-dose heparin.
Answers are grounded in this paper and cite their sources.
Low-dose heparin associated with less bleeding/transfusion after CABG; hypothesis-generating and should not change practice without RCTs.
The biocompatibility of minimal extracorporeal circuits has improved; however, anticoagulation is still required. We compared standard high-dose anticoagulation with a low-dose heparin regimen in a retrospective study of patients who underwent coronary bypass surgery using minimal cardiopulmonary bypass. One hundred patients who received 300 IU.kg(-1) heparin were compared with 68 patients who received heparin according to an individually adjusted activated coagulation time target of 300 s, resulting in a mean (SD) heparin dose of 145 (30) IU.kg(-1) . There were no thromboembolic events in either group; however, patients in the low-dose group had lower 24-hour mean (SD) postoperative blood loss than the conventional group (545 (61) vs 680 (88) ml, p=0.001) and a reduced rate of transfusion of allogeneic blood (15% patients transfused vs 32%, p=0.01). An individually tailored low-dose heparin regimen for minimal cardiopulmonary bypass is safe and may be associated with reduced bleeding and lower transfusion requirements.
No takes yet. Share an insight, caveat, or question.
Fromes et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: